GIP - gastric inhibitory polypeptide Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101080591
GIP Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_023244264.2 | XP_023100032.2 | gastric inhibitory polypeptide |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
gastric inhibitory polypeptide |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13749 | Sitagliptin | Inhibitor | 99.94% | Yes |
| HY-13749A | Sitagliptin phosphate | Inhibitor | 99.88% | Yes |
| HY-13749B | Sitagliptin phosphate monohydrate | Inhibitor | 99.83% | Yes |
| HY-13749AR | Sitagliptin phosphate (Standard) | Inhibitor | 99.82% | Unkown |
| HY-13749E | Sitagliptin hydrochloride | Inhibitor | / | Unkown |
| HY-13749R | Sitagliptin (Standard) | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P11672 | Poterepatide | Agonist | 99.78% | Phase 3 |
| HY-P0165B | Taspoglutide acetate | Agonist | / | Phase 3 |
| HY-164535 | Maridebart cafraglutide | 99.24% | Phase 1 | |
| HY-P10959 | Macupatide | Agonist | 99.99% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(59)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P0276 | GIP, human | Agonist | 99.94% | Unkown |
| HY-P10138 | human GIP(3-30), amide | Antagonist | 99.76% | Unkown |
| HY-P3247 | [D-Ala2]-GIP (human) | Agonist | 99.95% | Unkown |
| HY-P0276A | GIP, human TFA | Agonist | 99.15% | Unkown |
| HY-P10735 | GIP (mouse) | 98.79% | Unkown | |
| HY-P2542 | GIP (3-42), human | Antagonist | 99.75% | Unkown |
| HY-P10138A | human GIP(3-30), amide TFA | Antagonist | 96.90% | Unkown |
| HY-P2080B | GIP (1-30) amide,human acetate | Agonist | 99.27% | Unkown |
| HY-P1434 | [Pro3]-GIP (mouse) | Antagonist | 98.84% | Unkown |
| HY-P11285A | LAGIPRA peptide TFA | Agonist | 98.65% | Unkown |
| HY-P3579 | Gastric Inhibitory Peptide, porcine | 99.12% | Unkown | |
| HY-P10302A | GLP-1R/GIPR agonist-1 (soduim) | Agonist | 98.24% | Unkown |
| HY-P11321A | IUB0271 hydrochloride | 98.67% | Unkown | |
| HY-P3584A | (Pro3) GIP, human TFA | 99.89% | Unkown | |
| HY-P11666 | Brenipatide | Agonist | 99.29% | Unkown |
| HY-P2541A | GIP (1-30) amide, porcine TFA | Agonist | 99.14% | Unkown |
| HY-P10959A | Macupatide acetate | Agonist | 99.95% | Unkown |
| HY-P10929 | Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH | 99.31% | Unkown | |
| HY-P11237 | Enicepatide | Agonist | 98.16% | Unkown |
| HY-P11271A | Ribupatide TFA | Agonist | 99.75% | Unkown |
| HY-13749AS | Sitagliptin-d4 phosphate | Inhibitor | 99.48% | Unkown |
| HY-P3580A | Acetyl Gastric Inhibitory Peptide (human) TFA | 99.70% | Unkown | |
| HY-13749S1 | Sitagliptin-d4 hydrochloride | Inhibitor | 99.36% | Unkown |
| HY-153476A | GIP/GLP-1 dual receptor agonist-1 sodium | Agonist | 98.33% | Unkown |
| HY-P10591 | Olatorepatide | 99.35% | Unkown | |
| HY-P10302 | GLP-1R/GIPR agonist-1 | Agonist | / | Unkown |
| HY-P10965 | Zovaglutide | Agonist | / | Unkown |
| HY-P11271 | Ribupatide | Agonist | 98.74% | Unkown |
| HY-P2080C | GIP (1-30)-Myr | Agonist | / | Unkown |
| HY-P3255 | DA-JC4 | Agonist | 99.27% | Unkown |
| HY-P3584 | (Pro3) GIP, human | Agonist | 99.79% | Unkown |
| HY-103545 | GIP (1-39) | Agonist | / | Unkown |
| HY-120493 | (rel)-AM-6226 | Agonist | / | Unkown |
| HY-120493A | AM-6226 | Agonist | / | Unkown |
| HY-13749S2 | Sitagliptin-d4 | Inhibitor | / | Unkown |
| HY-153476 | GIP/GLP-1 dual receptor agonist-1 | Agonist | / | Unkown |
| HY-162513 | DPP-4-IN-10 | Inhibitor | / | Unkown |
| HY-171302 | GLP-1R/GIPR agonist-2 | Agonist | / | Unkown |
| HY-E70397A | Dipeptidyl Peptidase IV, Porcine Kidney | / | Unkown | |
| HY-P10952 | Astepatide | Agonist | / | Unkown |
| HY-P10972 | GIP (22-51) human | / | Unkown | |
| HY-P11233 | Acmopatide | Agonist | / | Unkown |
| HY-P11270 | Relsipatide | Agonist | / | Unkown |
| HY-P11285 | LAGIPRA peptide | Agonist | / | Unkown |
| HY-P11321 | IUB0271 | / | Unkown | |
| HY-P11674 | Zantrutide | Agonist | / | Unkown |
| HY-P1433 | [Pro3]-GIP (Rat) | Agonist | / | Unkown |
| HY-P2080 | GIP (1-30) amide,human | Agonist | / | Unkown |
| HY-P2541 | GIP (1-30) amide, porcine | Agonist | / | Unkown |
| HY-P3577 | [Tyr0] Gastric Inhibitory Peptide (23-42), human | / | Unkown | |
| HY-P3578 | Gastric Inhibitory Polypeptide (1-30), porcine | Modulator | / | Unkown |
| HY-P3580 | Acetyl Gastric Inhibitory Peptide (human) | / | Unkown | |
| HY-RS01726 | C1QTNF1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05434 | GIP Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05535 | GNAI2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-13749S3 | Sitagliptin-d6 | Inhibitor | / | Unkown |
| HY-174832 | DPP-4-IN-16 | Inhibitor | / | Unkown |
| HY-RS16530 | Gip Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22961 | Gip Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service